Cargando…
Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markers
BACKGROUND: Duchenne muscular dystrophy, a fatal muscle-wasting disease, is characterized by dystrophin deficiency caused by mutations in the dystrophin gene. Skipping of a target dystrophin exon during splicing with antisense oligonucleotides is attracting much attention as the most plausible way t...
Autores principales: | Malueka, Rusdy Ghazali, Takaoka, Yutaka, Yagi, Mariko, Awano, Hiroyuki, Lee, Tomoko, Dwianingsih, Ery Kus, Nishida, Atsushi, Takeshima, Yasuhiro, Matsuo, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350383/ https://www.ncbi.nlm.nih.gov/pubmed/22462762 http://dx.doi.org/10.1186/1471-2156-13-23 |
Ejemplares similares
-
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
por: Nishida, Atsushi, et al.
Publicado: (2011) -
Mutation spectrum analysis of
DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients
por: Dwianingsih, Ery Kus, et al.
Publicado: (2023) -
2′-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 Skipping
por: Lee, Tomoko, et al.
Publicado: (2017) -
Diagnostic Accuracy of Immunohistochemistry in Detecting MGMT Methylation Status in Patients with Glioma
por: Sahara, Nita, et al.
Publicado: (2021) -
Seizure in Indonesian Glioma Patients: Associated Risk Factors and Impact on Survival
por: Hartanto, Rachmat Andi, et al.
Publicado: (2021)